Search for
Toll-free
800.965.1461
Fax
415.568.2556
Office
415.568.2555
 
Menubar Left Corner Menubar Right Corner
Allegations of Shareholder Fraud Against MedImmune Inc.::

If you are a shareholder of MedImmune Inc. (MEDI), you are urged to contact the law offices of Audet & Partners at 800.965.1461 to speak to an attorney. The call is free and there is no obligation. You may also email us by using the simple form that appears on the right-hand side of this page. Act now, as delays can harm your case.

"The deal will send significant sums of cash toward MedImmune's highest ranks. President and CEO David Mott, who is named as a defendant in the class-action suit, is the largest shareholder of the company's executive team. In all, his nearly 5 million shares, or 2 percent of the company, give him $286.7 million under AstraZeneca's purchase plan." [more. . .] (from WBJ)
Introduction

A MedImmune shareholder has filed a class-action lawsuit against MedImmune Inc., its executives and directors, claiming the $15.6 billion buyout deal MedImmune hammered out with British-based AstraZeneca benefits MedImmune more than it does their public stockholders.

Allegations in the complaint allege that "[i]nstead of attempting to obtain the highest value reasonably available for the company's stockholders, defendants spent a substantial effort tailoring the acquisition to meet the specific needs of AstraZeneca."

If you are a shareholder of MedImmune Inc.(MEDI), you are urged to contact the law offices of Audet & Partners at 800.965.1461 to speak to an attorney. The call is free and there is no obligation. You may also contact us. Act now, as delays can harm your case.

 
Important Notice
Persons seeking to preserve any potential legal claims should contact an attorney promptly, since all states have mandatory time periods in which lawsuits must be filed with the courts; otherwise, they may be forever barred.
About Our Firm
Audet & Partners represents individuals, governmental entities, small businesses and institutional shareholders in product liability, tort, negligence, consumer, construction defect, investment fraud, securities, insider trading, antitrust, environmental, whistle blower, aviation and employment cases. In recognition of their outstanding abilities and commitment to the legal profession over the years, the firm and its members have served as Court-appointed Plaintiffs’ Counsel in dozens of federal and state cases throughout the United States.

If you may have been harmed by heparin, call us at 800.965.1461 or fill the secure form below

First name*
Last name*
Email*
Day phone*
Night phone*
When is the best time to call (and what is your time zone, e.g. PST, EST, etc.)?*
Your number, street, apt.*
City*
State/Province (two letter abbreviation)*
Zip
On what date(s) did you purchase the MEDI stock?

(MM/DD/YYYY)
Total number of shares owned
Describe in clear detail any additional facts that will help us evaluate your potential case:*
How did you find our site?
Search Engine (google, etc.)
Another Website
Print Ad
Print Yellow Pages
Television Ad
Radio Show
Word of Mouth
Other
Not Specified

Please be aware that the transmission of an e-mail inquiry itself does not create an attorney-client relationship.

Audet & Partners cannot serve as your counsel in any matter unless you and our firm expressly agree in writing that we serve as your attorney. You should also be aware that the Statute of Limitations (the deadline imposed by law within which you may bring a lawsuit) may severely limit the time remaining for you to file any potential claims you may have.

Email is sometimes unreliable. If we do not respond to you in a reasonable amount of time, please feel free to call us at 800.965.1461.